him and hers tirzepatide Zepbound Now Available Through Hims High dosed Wegovy (semaglutide) closing

While tirzepatide is not contraindicated in Graves disease, careful consideration of thyroid status, medication interactions, and monitoring requirements is essential

Understanding which one you have changes everything about storage expectations and planning

Switching to a different GLP-1 If cost is the primary driver, switching from tirzepatide to semaglutide may offer a more affordable alternative while maintaining GLP-1 receptor activation

Key benefits of weekly dosing include: Sustained appetite suppression throughout the week Consistent improvements in insulin sensitivity and blood sugar regulation Lower incidence of side effects compared to more frequent dosing Increased adherence due to the simplicity of the schedule Consistency is crucialskipping doses or injecting sporadically can lead to diminished results and a return of cravings or poor glucose control